gefitinib Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients. Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications The agency approved the test for use across solid tumors and with multiple companion diagnostic indications including one for prostate cancer and three for lung cancer. China's NMPA Extends Approval for Roche Cobas EGFR Mutation Test v2 to Plasma Samples Labs in China can now use the Cobas EGFR Mutation Test v2 with either tissue or plasma samples as a CDx for three Roche oncology drugs in NSCLC patients. FDA Approves Roche Cobas EGFR Mutation Test as CDx for Iressa The approval includes the use of either tumor tissue or plasma and follows previous approvals with Genentech's Tarceva (erlotinib) and AstraZeneca's Tagrisso (osimertinib). Lung Cancer Study Investigates Role of Protein Modifications in Cell Signaling, Drug Response Premium The study combined large-scale protein post-translational modification datasets with protein-protein interaction data to profile cell signaling in lung cancer. Jun 27, 2016 Precision Lung Cancer Drugs on Pricing Evaluation Group's Agenda Premium Jul 14, 2015 Iressa Approval Grows Options for Lung Cancer Patients as AstraZeneca Re-establishes Presence Premium Jul 13, 2015 FDA Approves Qiagen's Therascreen EGFR Test as CDx for AstraZeneca NSCLC Drug Breaking News In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis Euformatics Gains CE-IVD Mark for OmnomicsNGS People in the News: New Appointments at SomaLogic, 23andMe, Pacific Biosciences, More New Products Posted to GenomeWeb: GenDx, Eurofins Technologies, Codex DNA, More Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease The Scan Steps for Quick Review The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal. Moving Away From Using Term 'Race' A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports. Point of the Program The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question. Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.